Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 20, Issue 6

November-December 2023

In this Issue

ASH Image Bank Challenge
Clinical Trials Corner
Diffusion
Feature
Headlines from Washington
Mini Review
President’s Column

ASH Image Bank Challenge

An Older Woman with Progressive Lymphadenopathy

Akhil Jain, MD,Sanam Loghavi, MD,Yesid Alvarado, MD

View Articletitled, An Older Woman with Progressive Lymphadenopathy

Clinical Trials Corner

Bitopertin for Erythropoietic Protoporphyria: A New Paradigm — and New Hope — for a Rare, Devastating Disease

Michael Scott, MD

View Articletitled, Bitopertin for Erythropoietic Protoporphyria: A New Paradigm — and New Hope — for a Rare, Devastating Disease

MAHOGANY: Will it Establish Zanbrutinib, a Second-generation Bruton Tyrosine Kinase Inhibitor, as a Preferred Targeted Therapy for Relapsed/Refractory Follicular and Marginal Zone Lymphomas?

Loretta J. Nastoupil, MD

View Articletitled, MAHOGANY: Will it Establish Zanbrutinib, a Second-generation Bruton Tyrosine Kinase Inhibitor, as a Preferred Targeted Therapy for Relapsed/Refractory Follicular and Marginal Zone Lymphomas?

Two National Clinical Trials Poised to Expand the Role of Bone Marrow Transplant in Newly Diagnosed Severe Aplastic Anemia

Lori Muffly, MD, MS

View Articletitled, Two National Clinical Trials Poised to Expand the Role of Bone Marrow Transplant in Newly Diagnosed Severe Aplastic Anemia

Diffusion

Impact of Time-to-relapse on Biology, Evolutionary Dynamics, and Chemosensitivity in Diffuse Large B-cell Lymphoma

James K. Godfrey, MD,Alex F. Herrera, MD

View Articletitled, Impact of Time-to-relapse on Biology, Evolutionary Dynamics, and Chemosensitivity in Diffuse Large B-cell Lymphoma

Microbial Control of Acute Graft-versus-host Disease: Another Puzzle Piece Falls Into Place

Kate A. Markey, MBBS, PhD, MClinRes

View Articletitled, Microbial Control of Acute Graft-versus-host Disease: Another Puzzle Piece Falls Into Place

COMMANDing Anemia in Lower-risk Myelodysplastic Syndromes: Luspatercept Versus Erythropoiesis-stimulating Agents

Christine M. McMahon, MD

View Articletitled, COMMANDing Anemia in Lower-risk Myelodysplastic Syndromes: Luspatercept Versus Erythropoiesis-stimulating Agents

Pirtobrutinib: The Next Generation of Bruton Tyrosine Kinase Inhibitor for Use in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Prioty Islam, MD,Saad Z. Usmani, MD, MBA

View Articletitled, Pirtobrutinib: The Next Generation of Bruton Tyrosine Kinase Inhibitor for Use in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

Haley Newman, MD,Sarah K. Tasian, MD

View Articletitled, The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

Mental Health Disorders Are Prevalent and Influence Outcomes in Patients With Sickle Cell Disease

Samuel R. Wilson, MD, MSCR

View Articletitled, Mental Health Disorders Are Prevalent and Influence Outcomes in Patients With Sickle Cell Disease

The Dynamics of Engraftment After Stem Cell Transplant: Clonal Expansion by Chance

Katelynn M. Wilton, MD, PhD,Robert P. Hasserjian, MD

View Articletitled, The Dynamics of Engraftment After Stem Cell Transplant: Clonal Expansion by Chance

Feature

An Ode to the ASH Clinical Research Training Institute (CRTI) on Its 20th Anniversary

Wendy Stock, MD

View Articletitled, An Ode to the ASH Clinical Research Training Institute (CRTI) on Its 20th Anniversary

Not So Benign
Progress in Hemophilia: Emerging Triumph Over Adversity

Nigel S. Key, MBChB

View Articletitled, Not So Benign Progress in Hemophilia: Emerging Triumph Over Adversity

Committee Corner
Systems-Based Hematology: Where We Have Been and Where We Are Going

Marc S. Zumberg, MD,Surbhi Shah, MBBS, MD,Ming Y. Lim, MD

View Articletitled, Committee Corner Systems-Based Hematology: Where We Have Been and Where We Are Going

Headlines from Washington

Take Action on Behalf of Public Health and Hematology

View Articletitled, Take Action on Behalf of Public Health and Hematology

Mini Review

Not So Benign
Hereditary Hemorrhagic Telangiectasia: More Than Just Recurrent Nosebleeds

Callie Berkowitz, MD,Raj S. Kasthuri, MBBS

View Articletitled, Not So Benign Hereditary Hemorrhagic Telangiectasia: More Than Just Recurrent Nosebleeds

President’s Column

Reflections on a Year as ASH President

Robert A. Brodsky, MD

View Articletitled, Reflections on a Year as ASH President

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

ASH Image Bank Challenge

An Older Woman with Progressive Lymphadenopathy

Clinical Trials Corner

Bitopertin for Erythropoietic Protoporphyria: A New Paradigm — and New Hope — for a Rare, Devastating Disease

MAHOGANY: Will it Establish Zanbrutinib, a Second-generation Bruton Tyrosine Kinase Inhibitor, as a Preferred Targeted Therapy for Relapsed/Refractory Follicular and Marginal Zone Lymphomas?

Two National Clinical Trials Poised to Expand the Role of Bone Marrow Transplant in Newly Diagnosed Severe Aplastic Anemia

Diffusion

Impact of Time-to-relapse on Biology, Evolutionary Dynamics, and Chemosensitivity in Diffuse Large B-cell Lymphoma

Microbial Control of Acute Graft-versus-host Disease: Another Puzzle Piece Falls Into Place

COMMANDing Anemia in Lower-risk Myelodysplastic Syndromes: Luspatercept Versus Erythropoiesis-stimulating Agents

Pirtobrutinib: The Next Generation of Bruton Tyrosine Kinase Inhibitor for Use in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

Mental Health Disorders Are Prevalent and Influence Outcomes in Patients With Sickle Cell Disease

The Dynamics of Engraftment After Stem Cell Transplant: Clonal Expansion by Chance

Feature

An Ode to the ASH Clinical Research Training Institute (CRTI) on Its 20th Anniversary

Not So Benign
Progress in Hemophilia: Emerging Triumph Over Adversity

Committee Corner
Systems-Based Hematology: Where We Have Been and Where We Are Going

Headlines from Washington

Take Action on Behalf of Public Health and Hematology

Mini Review

Not So Benign
Hereditary Hemorrhagic Telangiectasia: More Than Just Recurrent Nosebleeds

President’s Column

Reflections on a Year as ASH President

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

ASH Image Bank Challenge

Clinical Trials Corner

Diffusion

Feature

Headlines from Washington

Mini Review

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only